Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marwan G Fakih

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
JOP : Journal of the Pancreas|May 11, 2006
Gemcitabine-induced rectus abdominus radiation recallMarwan G Fakih
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2008
Carcinoembryonic antigen monitoring in metastatic colorectal cancer: words of cautionMarwan G Fakih
The Oncologist|January 14, 2018
Trastuzumab Plus Pertuzumab Resistance Does Not Preclude Response to Lapatinib Plus Trastuzumab in HER2-Amplified Colorectal CancerMarwan G Fakih
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2015
Metastatic colorectal cancer: current state and future directionsMarwan G Fakih
Future Oncology (London, England)|February 25, 2011
Making sense of anti-EGFR plus oxaliplatin-based therapy in the first-line treatment of metastatic colorectal cancerMarwan G Fakih
Oncology|November 24, 2004
5-fluorouracil leucovorin and oxaliplatin (FOLFOX) in the treatment of metastatic colon cancer with severe liver dysfunctionMarwan G Fakih
The New England Journal of Medicine|July 10, 2024
Sotorasib in KRAS-Mutated Colorectal Cancer. ReplyMarwan G Fakih, Joseph Chao
Oncology (Williston Park, N.Y.)|June 16, 2006
CEA monitoring in colorectal cancer. What you should knowMarwan G Fakih, Aruna Padmanabhan
Anticancer Research|January 29, 2011
5-FU-induced hyperammonemic encephalopathy in a case of metastatic rectal adenocarcinoid successfully rechallenged with the fluoropyrimidine analog, capecitabinePooja P Advani, Marwan G Fakih
Clinical Colorectal Cancer|February 11, 2009
Does celecoxib have a role in the treatment of patients with colorectal cancer?Marwan G Fakih, Youcef M Rustum
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
JOP : Journal of the Pancreas|May 11, 2006
Gemcitabine-induced rectus abdominus radiation recallMarwan G Fakih
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2008
Carcinoembryonic antigen monitoring in metastatic colorectal cancer: words of cautionMarwan G Fakih
The Oncologist|January 14, 2018
Trastuzumab Plus Pertuzumab Resistance Does Not Preclude Response to Lapatinib Plus Trastuzumab in HER2-Amplified Colorectal CancerMarwan G Fakih
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2015
Metastatic colorectal cancer: current state and future directionsMarwan G Fakih
Future Oncology (London, England)|February 25, 2011
Making sense of anti-EGFR plus oxaliplatin-based therapy in the first-line treatment of metastatic colorectal cancerMarwan G Fakih
Oncology|November 24, 2004
5-fluorouracil leucovorin and oxaliplatin (FOLFOX) in the treatment of metastatic colon cancer with severe liver dysfunctionMarwan G Fakih
The New England Journal of Medicine|July 10, 2024
Sotorasib in KRAS-Mutated Colorectal Cancer. ReplyMarwan G Fakih, Joseph Chao
Oncology (Williston Park, N.Y.)|June 16, 2006
CEA monitoring in colorectal cancer. What you should knowMarwan G Fakih, Aruna Padmanabhan
Anticancer Research|January 29, 2011
5-FU-induced hyperammonemic encephalopathy in a case of metastatic rectal adenocarcinoid successfully rechallenged with the fluoropyrimidine analog, capecitabinePooja P Advani, Marwan G Fakih
Clinical Colorectal Cancer|February 11, 2009
Does celecoxib have a role in the treatment of patients with colorectal cancer?Marwan G Fakih, Youcef M Rustum
Pageof 9